| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −27.7× | −1.7× | |
| Price / Book | −19.5× | 2.0× | |
| Price / Sales | 85.9× | 3.9× | |
| Price / Free cash flow | −31.5× | −1.6× | |
| EV / EBITDA | −47.1× | −1.1× | |
| Earnings yield | −3.6% | −14.6% | |
| Free cash flow yield | −3.2% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,251.70 | −0.42% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.31 | −0.49% | $612.86B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $284.42 | −0.35% | $502.6B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $404.50 | +0.76% | $363.08B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.52 | −0.98% | $356.56B | 19.7× | 34.7% | +73.5% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.59 | −0.02% | $278.58B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.85 | −0.34% | $255.67B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $679.97 | −1.45% | $251.42B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $428.08 | −1.02% | $231.43B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.74 | −0.93% | $191.87B | 22.8× | 37.5% | +32.0% |
